Beyond the Benchmarks: What 10 Unclassified Stocks Reveal About the 2026 EconomyGlobal Report·2 days ago, 04:12 AMNVR-1.38%KEN-5.32%
Intellia Stock And 2 Growth Shares With Clear Earnings UpsideSimplywall·Jul 21 at 04:04 AMNTLA-0.83%PODD+1.88%
Intellia Therapeutics shares are trading lower after Wolfe Research downgraded the stock from Peer Perform to Underperform rating and announced a $9 price target.benzinga_article·Jul 16 at 09:40 AMNTLA-0.83%
This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursdaybenzinga_article·Jul 16 at 06:15 AMIONS-2.28%PNR-0.27%
Intellia Therapeutics (NTLA) Gets a Hold from WedbushTip Ranks·Jul 10 at 09:05 AMNTLA-0.83%RANK-2.56%
Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Rating of "Hold" by AnalystsMarket Beat·Jul 9 at 03:14 AMNTLA-0.83%
Intellia CFO Edward J. Dulac III disposes of 4,677 common shares valued at $84,186PUBT·Jul 6 at 04:01 PMNTLA-0.83%
Intellia grants 53,250 inducement RSUs to 13 new hires under 2024 planPUBT·Jul 6 at 03:05 PMNTLA-0.83%
As AbbVie eyes Apogee, these biotech stocks earn the highest quant ratingsMSN·Jun 22 at 08:55 AMNTLA-0.83%LEGN-1.00%
This Stock Is Up 58% This Year. Is It too Late to Buy?Motley Fool·Jun 17 at 01:50 AMNTLA-0.83%REGN+3.00%
Top Biotech Gainers: RGNT Withdraws F-1 Filing, FDA Clears CUPR's Maggot Therapy, MYO On Watchrttnews·Jun 15 at 09:32 PMHIMS-14.73%RGNT0.00%
